Chronic lower back pain (CLBP) is a leading cause of disability worldwide. Nonspecific or primary CLBP is defined as persistent or recurrent pain persisting beyond three months without a clear underlying pathology such as an inflammatory autoimmune condition or structural lesion.
It significantly affects quality of life, function, and mental wellbeing.
CLBP is primarily a clinical diagnosis based on history and clinical examination:
evaluate pain characteristics (onset, duration, aggravating/alleviating factors, radiation, and functional impact)
assess for psychological distress, PTSD, and social determinants impacting pain perception
perform a physical examination, including gait assessment, neurological testing (reflexes, sensation, strength), and provocative tests (eg, straight leg raise for radiculopathy)
note that radiating pain down the leg may also be associated with nonspecific CLBP
Differential diagnoses for chronic lower back pain:
mechanical CLBP is the most common (eg, muscle strain, facet joint arthritis, degenerative disc disease)
radiculopathy (eg, sciatica, lumbar disc herniation, foraminal stenosis)
serious pathologies and red flags when assessing CLBP include:
spinal osteomyelitis or epidural abscess (fever, IV drug use, immunosuppression)
malignancy (unexplained weight loss, history of cancer, pain at multiple sites, pain at rest)
vertebral fracture (trauma history, osteoporosis, chronic steroid use)
cauda equina syndrome (bilateral or alternating radiculopathy, saddle anaesthesia, bowel/bladder dysfunction, severe motor weakness - refer urgently)
myelopathy (gait disturbance, reduced balance, clonus, sensory loss)
axial spondyloarthritis (young age (<40 years), prolonged morning stiffness, alternating buttock pain, improvement with activity, and failure to improve with rest)
Imaging:
not required for most cases unless red flags are present or symptoms persist despite conservative management for >6 weeks
MRI is preferred if neurological deficits or suspected malignancy/infection due to superior sensitivity and safety
The World Health Organisation recommends a non-surgical, multimodal approach integrating education, physical, psychological, and pharmacological interventions. This integrated biopsychosocial approach is considered to be the most effective.
For all interventions, emphasise functional improvement over pain elimination.
Education and self-management:
provide structured, standardised education about the pain experience, such as benefits of physical activity, ergonomic advice, self-care strategies, and engagement in social and work activities
note that not all patients may appreciate or benefit from education for management of their pain and may have preference for alternative interventions
consider directing patients to the MyBackPain resource here
Physical therapy and exercise:
encourage regular, individualised exercise programs
no exercise modality is superior to another
comprehensive guidelines on physical activity and sedentary behaviour can be found here
evidence for spinal manipulation or massage is unclear. It may be beneficial as an adjunct therapy but any contraindications (particularly to manipulation) must be first identified, such as osteoporosis
Psychological interventions:
cognitive behavioural therapy (CBT) helps manage pain-related distress and mental illness, and improves coping strategies
mindfulness-based stress reduction may be considered but there is insufficient evidence to recommend for or against
if significant PTSD, depression, or opioid dependence, refer for psychiatry/psychology assessment
Assistive devices:
mobility aids may help selected patients with significant disability
lumbar braces/belts are not recommended for routine use
Non-steroidal anti-inflammatory drugs (NSAIDs) are first-line for pain relief, used intermittently at the lowest effective dose
most NSAIDs are considered equally effective, including ibuprofen, indometacin, diclofenac, piroxicam, naproxen, meloxicam, ketoprofen, etoricoxib, and celecoxib
consider prescribing a gastro-protective medication to reduce the risk of gastrointestinal complications
there is insufficient evidence to support the efficacy of paracetamol in CLBP, though it may have a role if NSAIDs are unsuitable
anticonvulsants, tricyclic antidepressants, selective serotonin and noradrenalin reuptake inhibitors, cannabinoids, and benzodiazepines are not recommended due to limited efficacy and the potential for harm
opioids should be avoided in chronic non-cancer pain due to high addiction risk, and minimal evidence for long-term benefit
corticosteroid injections and local anaesthetic blocks have not demonstrated significant treatment benefit for nonspecific lower back pain
Acupuncture/needling may provide short-term relief
caution patients on anticoagulants due to risk of bleeding at needling sites
transcutaneous electrical nerve stimulation (TENS), traction, and therapeutic ultrasound are not recommended due to limited evidence
If the pain is refractory to multimodal treatment after 6 to 12 weeks, consider referral for specialist pain management.
Certain factors increase the likelihood of a poor prognosis for primary CLBP:
more severe pain at presentation
higher level of disability at presentation
concurrent leg pain
older age
mental illness, including anxiety and depression
poor overall health
A poor understanding of the nature of primary CLBP may also increase the risk of an unfavourable prognosis due to unhelpful or harmful adaptive behaviours. Patients should be educated that:
pain during physical activity doesn’t necessarily equate to further damage and injury
active participation in management strategies are more effective than passive therapies (such as massage or acupuncture) alone
engaging with their usual physical activities as much as possible, as well as working, can aid recovery
prolonged bed rest and a sedentary lifestyle is unhelpful and may result in protracted pain, muscle wasting, and physical deconditioning
After reading the clinical summary above and reviewing the references, complete the quiz to gain 30 minutes of EA CPD and 30 minutes of RP CPD.
You can either self-report CPD to your CPD home, or Medcast will track your learning via your personal CPD Tracker and you can download and report these points once a year. See our CPD Tracker FAQ.
Complete the following five (5) questions, and review the answers to complete this learning activity
WHO guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings. Geneva: World Health Organisation; 2023. Licence: CC BY-NC-SA 3.0 IGO. (last accessed February 2025).
Australian Commission on Safety and Quality in Health Care. Low Back Pain Clinical Care Standard (2022). 2022. (last accessed February 2025).
Therapeutic Guidelines. Nonspecific low back pain. 2024. (last accessed February 2025).
The Medcast medical education team is a group of highly experienced, practicing GPs, health professionals and medical writers.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreAsthma is a long-term inflammatory condition of the airways, marked by episodes of wheezing, breathlessness, chest tightness, and coughing, with airflow restriction that varies over time. This FastTrack-CPD provides a clinical summary on the management of asthma with a quiz to apply your learning and receive CPD (RP and EA categories).
Crohn’s disease (CD) is a chronic inflammatory bowel disease affecting any part of the GI tract. It has genetic and environmental triggers and presents with symptoms like abdominal pain, diarrhoea, and weight loss. Diagnosis involves endoscopy and imaging. Management includes corticosteroids, biologics, immunomodulators, lifestyle changes, and psychological support. This FastTrack-CPD provides a clinical summary on the management of Crohn's disease with a quiz to apply your learning and receive CPD (RP and EA categories).
Polycystic ovary syndrome (PCOS) affects 10–13% of women, with higher prevalence in certain ethnic groups. It is characterized by hyperandrogenism, menstrual irregularities, and polycystic ovarian morphology. PCOS increases the risk of type 2 diabetes, cardiovascular disease, and requires early diagnosis and personalized management to reduce long-term effects. This FastTrack-CPD provides a clinical summary on the management of PCOS with a quiz to apply your learning and receive CPD (RP and EA categories).